Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.
Fiche publication
Date publication
février 2014
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOUVIER Anne-Marie
Tous les auteurs :
Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, Canva V, Louvet A, Deltenre P, Boleslawski E, Truant S, Pruvot FR, Dharancy S
Lien Pubmed
Résumé
In light of the impact of emerging hepatitis C virus treatments on morbidity and mortality, we sought to determine whether candidates for liver transplantation for hepatocellular carcinoma and decompensated cirrhosis will decrease sufficiently to match liver grafts for hepatitis C virus-infected patients.
Mots clés
Antiviral Agents, therapeutic use, Carcinoma, Hepatocellular, etiology, France, Hepatitis C, Chronic, complications, Humans, Liver Cirrhosis, etiology, Liver Neoplasms, etiology, Liver Transplantation, Markov Chains, Tissue and Organ Procurement, Transplants, supply & distribution
Référence
Dig Liver Dis. 2014 Feb;46(2):157-63